Cunningham, MJ; Bock, HA; Serrano, IC; Bechand, B; Vidyadhara, DJ; Bonniwell, EM; Lankri, D; Duggan, P; Nazarova, AL; Cao, AB; Calkins, MM; Khirsariya, P; Hwu, C; Katritch, V; Chandra, SS; McCorvy, JD; Sames, D. Pharmacological mechanism of the non-hallucinogenic 5-HT2A agonist Ariadne and analogs. ACS Chem. Neurosci., 15 Dec 2022, n/a. 15.3 MB. https://doi.org/10.1021/acschemneuro.2c00597 #38 MS,NMR,other
N-Ethyl-α-propyl-3,4-methylenedioxyphenethylamine · ETHYL-K
N-Butyl-3,4-methylenedioxyamphetamine · N-Butyl-MDA · MDBU
N-Isobutyl-3,4-methylenedioxyamphetamine · MDIB
N-tert-Butyl-3,4-methylenedioxyamphetamine · MDTB
METHYL-L · α-Bu-N-Me-MDPEA · α-Butyl-N-methyl-3,4-methylenedioxyphenethylamine
N-Methyl-N-propyl-3,4-methylenedioxyamphetamine · MDMPA
N-Methyl-N-isopropyl-3,4-methylenedioxyamphetamine · MDMIPA
PBDB · α-Ethyl-N-propyl-3,4-methylenedioxyphenethylamine
IPBDB · α-Ethyl-N-isopropyl-3,4-methylenedioxyphenethylamine
4,7-Dimethoxy-6-methyl-2-(dimethylamino)indane · N,N-Me-DOMAI
α-Al-N-Me-2,6-DMPEA · α-Allyl-N-methyl-2,6-dimethoxyphenethylamine
α-Al-N-Me-3,5-DMPEA · α-Allyl-N-methyl-3,5-dimethoxyphenethylamine
ATK-0102 · α-tert-Butyl-N-methyl-3,4-methylenedioxyphenethylamine · α-tBu-N-Me-3,4-MDPEA
4-Methallyl-3,5-dimethoxyphenethylamine · DMAL
2C-MAL-2 · 4-(1-Methylallyl)-2,5-dimethoxyphenethylamine
2C-CB · 4-Cyclobutyl-2,5-dimethoxyphenethylamine
2C-MAL · 4-Methallyl-2,5-dimethoxyphenethylamine
N-tert-Butyl-3-methoxycathinone